This was the stock's second consecutive day of losses.

Non-active site mutations such as L50F are crucial for restoring the viral fitness of SARS-CoV-2 main protease. Here, the authors use full-length Mpro protein as substrate and demonstrate that ...

Let's talk about the popular Lam Research Corporation (NASDAQ:LRCX). The company's shares saw a decent share price growth of 16% on the NASDAQGS over the last few months. Shareholders may ...

High-rolling investors have positioned themselves bullish on Lam Research LRCX, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's ...

As of 9:52 a.m. ET, shares are up .8% at $392 per share. Lam Research shares initially declined but are now up 5.5%. Looking at the broader technology space, Meta Platforms is up 4.2% and has seen ...

(Reuters) – Chip-making equipment supplier Lam Research forecast third-quarter revenue above Wall Street expectations on Wednesday, driven by a surge in orders from chip firms amid the AI boom. Shares ...

Investing.com -- Bernstein upgraded Lam Research (NASDAQ:LRCX) to Outperform from Market-Perform, citing improving risk-reward dynamics and signs of a potential NAND recovery. The firm raised ...

In a report released today, Thomas O’Malley from Barclays maintained a Hold rating on Lam Research (LRCX – Research Report), with a price target of $75.00. The company’s shares closed ...